Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

Sanofi's Diabetes Drug Faces Scrutiny from FDA

May 24, 2016 | by Ryan Bushey, Digital Editor | Articles | Comments

An FDA advisory panel is meeting Wednesday to decide if this drug should be recommended for approval in the U.S. 


New Valeant CEO Discusses Turnaround Plan at Investor Conference

May 24, 2016 3:18 pm | by Ryan Bushey, Digital Editor | Articles | Comments

Joseph Papa shed on light on the potential strategy for reducing the drug maker's debt load.


EMA Accepts Submission for Rituximab Biosimilar

May 24, 2016 3:00 pm | News | Comments

Sandoz is committed to increasing patient access to high-quality, life-enhancing biosimilars.


EU Lifts Suicide Warning on Pfizer's Smoking-Cessation Pill

May 24, 2016 2:00 pm | by Linda A. Johnson, AP Medical Writer | News | Comments

Europe's main drug regulator has lifted a 7-year-old warning about possible suicidal risks from Chantix, Pfizer's smoking-cessation pill.


Breakthrough Could Help Sufferers of Deadly Lung Disease

May 24, 2016 1:00 pm | by University of Sheffield | News | Comments

For the first time scientists have identified a molecule that promotes the progression of the disease which affects 6,500 people in the UK.


Combination Immunotherapy Set to Become Integral Element of Renal Cell Carcinoma Treatment

May 24, 2016 11:39 am | by Maxime Bourgognon, PharmD, Oncology and Hematology Analyst, GlobalData | Articles | Comments

Combination approaches have the potential to generate twice as many sales in the recurrent RCC market.


Janssen's Stelara Maintained Clinical Remission After Year Of Treatment

May 24, 2016 9:21 am | News | Comments

Janssen Phase 3 data presented for the first time at Digestive Disease Week 2016 showed that a significantly greater proportion of adult patients with moderate to severe Crohn's disease receiving Stelara (ustekinumab) subcutaneous (SC) maintenance therapy were in clinical remission at one year. 


Breast Cancer Drug Discovery Offers Hope for New Treatments

May 24, 2016 8:41 am | by University of Edinburgh | News | Comments

A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.


Yellow Fever Epidemic Threatens Spread from Angola to China

May 24, 2016 8:39 am | by Elsevier Health Sciences | News | Comments

The spread of yellow fever is a global health threat.


Catching Metastatic Cancer Cells Before They Grow Into Tumors

May 24, 2016 8:38 am | by Rachel M. Dudek and Lonnie Shea, University of Michigan, The Conversation | News | Comments

“Cure” is a word that’s dominated the rhetoric in the war on cancer for decades.


Astellas, Daiichi Sankyo, and Takeda Announce R&D Collaboration on Biomarker Database

May 23, 2016 2:57 pm | News | Comments

All three firms aim to contribute to the enhancement of health and welfare of people around the world through creating innovative medicine.


Harvard Licenses Genotyping Platform

May 23, 2016 2:00 pm | by Harvard Gazette | News | Comments

The technology addresses the profound challenge of drug resistance among HIV-infected patients in resource-poor areas.


One Step Closer to Curing Diabetes

May 23, 2016 1:00 pm | by University of Technology, Sydney | News | Comments

The group is now working with US clinical stage biotechnology company PharmaCyte Biotech to commercialize the research.


Novartis' Entresto Gains Strong Recommendation for US, EU Heart Failure Guidelines

May 23, 2016 9:48 am | News | Comments

This decision was made less than a year after regulatory approvals. 


FDA Questions Novo's Phase 3 Data for Diabetes Drug

May 23, 2016 9:07 am | by Ryan Bushey, Digital Editor | Articles | Comments

This drug is projected to be an important source of revenue for Novo Nordisk.


Breaking Down Cancer Cell Defenses

May 23, 2016 8:52 am | by University of Pennsylvania | News | Comments

The mistaken activation of certain cell-surface receptors contributes to a variety of human cancers.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.